Human microbiotas are communities of microorganisms living in symbiosis with humans. They play an important role in the host immune response to respiratory viral infection. However, evidence on the ...human microbiome and coronavirus disease (COVID-19) relationship is insufficient. The aim of this systematic literature review was to evaluate existing evidence on the association between the microbiome and COVID-19 in humans and summarize these data in the pandemic era.
We conducted a systematic literature review on the association between the microbiome and COVID-19 in humans by searching PubMed, Embase, and the Cochrane Library, CINAHL, and Web of Science databases for articles in English published up to October 31, 2020. The results were analyzed qualitatively. This study is registered with PROSPERO (CRD42020195982).
Of the 543 articles identified by searching databases, 16 in line with the research objectives were eligible for qualitative review: eight sampled the microbiome using stool, four using nasopharyngeal or throat swab, three using bronchoalveolar lavage fluid, and one using lung tissue. Fecal microbiome dysbiosis and increased opportunistic pathogens were reported in COVID-19 patients. Several studies suggested the dysbiosis in the lung microbiome of COVID-19 patients with an abundance of opportunistic pathogens using lower respiratory tract samples. The association between COVID-19 severity and the human microbiome remains uncertain.
The human fecal and respiratory tract microbiome changed in COVID-19 patients with opportunistic pathogen abundance. Further research to elucidate the effect of alternation of the human microbiome in disease pathogenesis is warranted.
Abstract
Denosumab and romosozumab, a recently approved new drug, are effective and widely known molecular-targeted drugs for postmenopausal osteoporosis treatment. However, no studies have directly ...compared their therapeutic effects or safety in postmenopausal osteoporosis. This retrospective observational registry study compared the efficacy of 12-month denosumab or romosozumab treatment in postmenopausal osteoporosis patients. The primary outcome was the change in bone mineral density (BMD) at the lumbar spine. Secondary outcomes included BMD changes at the total hip and femoral neck, changes in bone turnover markers, and adverse events. Propensity score matching was employed to assemble patient groups with similar baseline characteristics. Sixty-nine patients each received either denosumab or romosozumab for 12 months. The mean 12-month percentage change from baseline in lumbar spine BMD was 7.2% in the denosumab group and 12.5% in the romosozumab group, indicating a significant difference between the groups. The percentage changes in BMD at both the total hip and femoral neck were also significantly higher at 12 months in the romosozumab group than in the denosumab group. In denosumab patients, bone formation and bone resorption markers were significantly decreased at 6 and 12 months from baseline. In the romosozumab group, the bone formation marker was significantly increased at 6 months and then returned to baseline, while the bone resorption marker was significantly decreased at both time points. Adverse events were few and predominantly minor in both groups, with no remarkable difference in the incidence of new vertebral fractures. Romosozumab showed a higher potential for improving BMD than denosumab in this clinical study of postmenopausal osteoporosis patient treatment.
Coronavirus disease is reported to affect the cardiovascular system. We showed that relative bradycardia was a common characteristic for 54 patients with PCR-confirmed mild-to-moderate coronavirus ...disease in Japan. This clinical sign could help clinicians to diagnose this disease.
Liquid-liquid phase separation (LLPS) of proteins containing intrinsically disordered regions (IDRs) has been proposed as a mechanism underlying the formation of membrane-less organelles. Tight ...regulation of IDR behavior is essential to ensure that LLPS only takes place when necessary. Here, we report that IDR acetylation/deacetylation regulates LLPS and assembly of stress granules (SGs), membrane-less organelles forming in response to stress. Acetylome analysis revealed that the RNA helicase DDX3X, an important component of SGs, is a novel substrate of the deacetylase HDAC6. The N-terminal IDR of DDX3X (IDR1) can undergo LLPS in vitro, and its acetylation at multiple lysine residues impairs the formation of liquid droplets. We also demonstrated that enhanced LLPS propensity through deacetylation of DDX3X-IDR1 by HDAC6 is necessary for SG maturation, but not initiation. Our analysis provides a mechanistic framework to understand how acetylation and deacetylation of IDRs regulate LLPS spatiotemporally, and impact membrane-less organelle formation in vivo.
Oligosaccharides possess fascinating functions that are applicable in a variety of fields, such as agriculture. However, the selective synthesis of oligosaccharides, especially ...chitin‐oligosaccharides, has remained a challenge. Chitin‐oligosaccharides activate the plant immune system, enabling crops to withstand pathogens without harmful agrichemicals. Here, we demonstrate the conversion of chitin to chitin‐oligosaccharides using a carbon catalyst with weak acid sites and mechanical milling. The catalyst produces chitin‐oligosaccharides with up to 94 % selectivity in good yields. Monte‐Carlo simulations indicate that our system preferentially hydrolyzes larger chitin molecules over oligomers, thus providing the desired high selectivity. This unique kinetics is in contrast to the fact that typical catalytic systems rapidly hydrolyze oligomers to monomers. Unlike other materials carbons more strongly adsorb large polysaccharides than small oligomers, which is suitable for the selective synthesis of small oligosaccharides.
An activated carbon catalyst having weak acid sites hydrolyzes chitin to chitin‐oligosaccharides selectively in the presence of mechanical milling. Our system preferentially cleaves large molecules over small oligomers, thus maximizing the selectivity and yield of chitin‐oligosaccharides. The product mixture is a promising plant biostimulant for environmentally friendly agriculture.
Oxygen-containing carbon materials such as graphene oxide have been studied intensively for a decade because of the high oxygen content, which is beneficial to disperse carbon materials in solutions ...and to support either metals or metal oxides on carbon materials. However, various oxygen-containing functional groups exist on carbon materials and controlling the structures is almost impossible. In this work, phloroglucinol (PG), which has a symmetrical structure with three hydroxyl groups relative to six aromatic carbon atoms, was found to be the best precursor among PG, cyanuric acid, trimesic acid, and melamine because of the high yield (63 wt%) at 573 K even in an open system which is essential for mass production. The materials synthesized from PG also showed the high dispersibility and/or solubility in solvents (
N
-methyl-2-pyrrolidone and
N
,
N
-dimethylformamide) and the low temperature to form carbon materials (573 K), which can be explained from (002) and (10) in X-ray diffraction pattern. X-ray photoelectron spectroscopy, Fourier transform infrared spectrometer, carbon-13 nuclear magnetic resonance with the aid of calculation of both spectra and carbonization mechanisms revealed that the high solubility of carbonized PG originates from the presence of ether and cyclic ether, which were formed from dehydration of hydroxy groups, and also some remained hydroxyl groups in carbonized PG. Oxygen-containing groups in carbonized PG were effective as an antioxidant. In addition, the coating of carbonized PG on silica nanoparticles imparted conductivity and lubricity to silica nanoparticles.
Graphic abstract
Most anti-influenza drugs currently used, such as oseltamivir and zanamivir, inhibit the enzymatic activity of neuraminidase. However, neuraminidase inhibitor-resistant viruses have already been ...identified from various influenza virus isolates. Here, we report the development of a class of macrocyclic peptides that bind the influenza viral envelope protein hemagglutinin, named iHA. Of 28 iHAs examined, iHA-24 and iHA-100 have inhibitory effects on the in vitro replication of a wide range of Group 1 influenza viruses. In particular, iHA-100 bifunctionally inhibits hemagglutinin-mediated adsorption and membrane fusion through binding to the stalk domain of hemagglutinin. Moreover, iHA-100 shows powerful efficacy in inhibiting the growth of highly pathogenic influenza viruses and preventing severe pneumonia at later stages of infection in mouse and non-human primate cynomolgus macaque models. This study shows the potential for developing cyclic peptides that can be produced more efficiently than antibodies and have multiple functions as next-generation, mid-sized biomolecules.
PDF
